These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 34380685)

  • 1. Transient acetylcholine receptor-related myasthenia gravis, post multisystem inflammatory syndrome in children (MIS-C) temporally associated with COVID-19 infection.
    Essajee F; Lishman J; Solomons R; Abraham DR; Goussard P; Van Toorn R
    BMJ Case Rep; 2021 Aug; 14(8):. PubMed ID: 34380685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneously resolving late-onset ocular myasthenia related to COVID-19. A case report.
    Popescu C
    Acta Myol; 2023; 42(2-3):89-91. PubMed ID: 38090545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New-onset Myasthenia Gravis after SARS-CoV-2 infection: case report and literature review.
    Tereshko Y; Gigli GL; Pez S; De Pellegrin A; Valente M
    J Neurol; 2023 Feb; 270(2):601-609. PubMed ID: 36352330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myasthenia gravis associated with novel coronavirus 2019 infection: A report of three cases.
    Karimi N; Okhovat AA; Ziaadini B; Haghi Ashtiani B; Nafissi S; Fatehi F
    Clin Neurol Neurosurg; 2021 Sep; 208():106834. PubMed ID: 34329810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal association between SARS-CoV-2 and new-onset myasthenia gravis: is it causal or coincidental?
    Muralidhar Reddy Y; B SK; Osman S; Murthy JMK
    BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34290032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of generalized disease at 2 years in patients with ocular myasthenia gravis.
    Kupersmith MJ; Latkany R; Homel P
    Arch Neurol; 2003 Feb; 60(2):243-8. PubMed ID: 12580710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment.
    Kupersmith MJ; Ying G
    Br J Ophthalmol; 2005 Oct; 89(10):1330-4. PubMed ID: 16170126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review.
    Sriwastava S; Tandon M; Kataria S; Daimee M; Sultan S
    J Neurol; 2021 Aug; 268(8):2690-2696. PubMed ID: 33047223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New-onset myasthenia gravis after mRNA SARS-CoV-2 vaccination: a case series.
    Fanella G; Baiata C; Candeloro E; Toscano G; Colnaghi S; Mauri M; Cariddi LP; Rebecchi V; Solazzo F; Banfi P; Piatti M; Ferrarese C; Versino M
    Neurol Sci; 2022 Oct; 43(10):5799-5802. PubMed ID: 35870026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manifestation of Ocular Myasthenia Gravis as an Initial Symptom of Coronavirus Disease 2019: A Case Report.
    Rahimian N; Alibeik N; Pishgar E; Dini P; Abolmaali M; Mirzaasgari Z
    Iran J Med Sci; 2022 Jul; 47(4):385-388. PubMed ID: 35919075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular myasthenia gravis: a review and practical guide for clinicians.
    Shuey NH
    Clin Exp Optom; 2022 Mar; 105(2):205-213. PubMed ID: 35157811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myasthenia gravis associated with anti-MuSK antibodies developed after SARS-CoV-2 infection.
    Assini A; Gandoglia I; Damato V; Rikani K; Evoli A; Del Sette M
    Eur J Neurol; 2021 Oct; 28(10):3537-3539. PubMed ID: 33421278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ophthalmologic clinical features of ocular myasthenia gravis.
    Kim DH; Roh HC; Oh SY
    Medicine (Baltimore); 2023 Jan; 102(2):e31972. PubMed ID: 36637960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated Bilateral Triceps Weakness in Myasthenia Gravis.
    Özenç B; Işık K; Odabaşı Z
    Acta Neurol Taiwan; 2024 Jun; 33(2)():73-75. PubMed ID: 37848221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Mummy, my eyelids are heavy": A case series of juvenile myasthenia gravis.
    Krishna L; Abdul Jalil NF; Lott PW; Singh S; Choo MM
    Eur J Ophthalmol; 2021 Mar; 31(2):NP119-NP122. PubMed ID: 31390886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response.
    Mittal MK; Barohn RJ; Pasnoor M; McVey A; Herbelin L; Whittaker T; Dimachkie M
    J Clin Neuromuscul Dis; 2011 Sep; 13(1):46-52. PubMed ID: 22361625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myasthenia gravis with a paraneoplastic marker.
    Leavitt JA
    J Neuroophthalmol; 2000 Jun; 20(2):102-5. PubMed ID: 10870923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decompensating esophoria as the presenting feature of myasthenia gravis.
    Arblaster GE; Shipman TL; Pepper IM
    J AAPOS; 2009 Jun; 13(3):310-1. PubMed ID: 19395293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-COVID simultaneous onset of Graves' disease and ocular myasthenia gravis in a patient with a complex ocular motility impairment.
    De Giglio L; Sadun F; Roberti C; Polidori L; Gilardi M; Altavista MC; Pennisi EM
    Eur J Ophthalmol; 2023 May; 33(3):NP49-NP51. PubMed ID: 35167395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 Vaccination and Late-Onset Myasthenia Gravis: A New Case Report and Review of the Literature.
    Virgilio E; Tondo G; Montabone C; Comi C
    Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.